Copertina

PET Response and Outcome in Low‐Risk Nodular Lymphocyte‐Predominant Hodgkin Lymphoma: Children's Oncology Group Study AHOD03P1

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Lianna J. Marks, Yue Wu, Kathleen M. McCarten, Lindsay A. Renfro, Qinglin Pei, Kara M. Kelly, Cindy L. Schwartz, Sharon M. Castellino, Burton E. Appel
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pediatric Blood & Cancer
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High‐Risk Pediatric Hodgkin Lymphoma Patients Treated on Children's Oncology Group AHOD1331
di: Jennifer A. Belsky, et al.
Pubblicazione: (2025)

Uniting for Change: The GLOW Initiative and Its Impact on Nodular Lymphocyte‐Predominant Hodgkin Lymphoma
di: Diana M. Fridlyand, et al.
Pubblicazione: (2025)

Global nLPHL One Working Group (GLOW) Research Roadmap for Nodular Lymphocyte‐Predominant Hodgkin Lymphoma
di: Monica Palese, et al.
Pubblicazione: (2025)

Neurologic Morbidity in Survivors of Childhood Hodgkin Lymphoma Treated With Radiation
di: Raja B. Khan, et al.
Pubblicazione: (2026)

“Techquity” in Pediatric, Adolescent, and Young Adult Oncology: Addressing Inequities Through Artificial Intelligence and Immersive Technologies
di: Vidya Puthenpura, et al.
Pubblicazione: (2025)

Successful Treatment of Isolated Bone Marrow Classic Hodgkin Lymphoma in a Patient With Cartilage Hair Hypoplasia
di: L. Benjamin Hills, et al.
Pubblicazione: (2026)

Nodular Lymphocyte‐Predominant Hodgkin Lymphoma: Update on Biology and Treatment
di: Peter Borchmann, et al.
Pubblicazione: (2025)

Current Treatment Strategies and Supportive Care Practices in the Care of Children and Adolescents With Mature B‐Cell Non‐Hodgkin Lymphoma: A Survey of Children's Oncology Group Institutions
di: Jennifer A. Belsky, et al.
Pubblicazione: (2025)

Systemic Epstein–Barr Virus–Positive T‐Cell Lymphoma of Childhood: A Case Series
di: Maiah Zarrabi, et al.
Pubblicazione: (2026)

Expanding the Malignancy Spectrum of Tatton‐Brown–Rahman Syndrome: A Case of Hodgkin Lymphoma
di: Shreyasi Das, et al.
Pubblicazione: (2026)

Efficacy and Safety of Bendamustine‐Rituximab for Nodular Lymphocyte Predominant Hodgkin Lymphoma
di: Alexander Robin, et al.
Pubblicazione: (2025)

Intestinal Low‐Dose Radiation to Overcome PD‐1 Resistance in Pediatric Relapsed/Refractory Hodgkin Lymphoma
di: Shubham Sahni, et al.
Pubblicazione: (2026)

Case of Refractory Classic Hodgkin Lymphoma With a Germline Pathogenic Monoallelic Variant in the TNFRSF13B Gene
di: Mónica Camacho‐Arias, et al.
Pubblicazione: (2024)

Circulating Tumor DNA in Pediatric Mature B‐Cell Non‐Hodgkin Lymphoma for Genotyping and Minimal Disease Monitoring
di: Jana Werner, et al.
Pubblicazione: (2025)

Histiocytic Sarcoma Arising in a Background of Nodular Lymphocyte Predominant Hodgkin Lymphoma
di: Gul Emek Yuksek Wymer, et al.
Pubblicazione: (2025)

The Threat of Medical Misinformation: A Case of Ivermectin Toxicity in a Pediatric Oncology Patient
di: Stephen Gilene, et al.
Pubblicazione: (2025)

Barriers to long‐term follow‐up in pediatric Hodgkin lymphoma survivors
di: Hailey Tinsley, et al.
Pubblicazione: (2024)

Toxicity profile of high‐dose methotrexate in young children with central nervous system tumors
di: Ashley N. Chavana, et al.
Pubblicazione: (2024)

Advice From Adolescents With Cancer, Their Caregivers, and Clinicians on Utilizing and Improving Patient Portals in Adolescent Oncology Care
di: Mary Claire McGlynn, et al.
Pubblicazione: (2026)

Standard‐Dose Versus High‐Dose Cisplatin for Intermediate/Poor‐Risk Extracranial Malignant Germ Cell Tumors: Re‐Analysis of Pediatric Oncology Group 9049 and Children's Cancer Group 8882 Trial Using Updated MaGIC Risk Stratification
di: Daniel Prior, et al.
Pubblicazione: (2025)

Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study‐5 and Children's Oncology Group Study AREN0321
di: James I. Geller, et al.
Pubblicazione: (2024)

Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Patients Using a Longitudinally-Aware Segmentation Network
di: Tie, Xin, et al.
Pubblicazione: (2024)

Inpatient Food Insecurity and Pediatric Hematology Oncology Hospitalization Outcomes
di: Joanna M. Robles, et al.
Pubblicazione: (2026)

Multifocal Nodular Fatty Infiltration of the Liver in a Child—A Benign Condition Masquerading as a Malignant Liver Tumor
di: Yu Lin, et al.
Pubblicazione: (2026)

Focal Nodular Hyperplasia (FNH)/FNH‐Like Lesions: An Important Potential Mimic of Relapsed Malignancy in Pediatric Cancer Patients
di: Jonathan Abrams, et al.
Pubblicazione: (2025)

Hyperinsulinism‐induced hypoglycemia secondary to asparaginase Erwinia chrysanthemi (recombinant)‐rywn chemotherapy in a pediatric AML patient
di: Ashley Carlo, et al.
Pubblicazione: (2024)

Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives
di: Kathryn S. Sutton, et al.
Pubblicazione: (2025)

Marginal Zone B‐Cell Lymphoma With Marked Plasmacytic Differentiation and Increased Large Cells in a Teenage Male With Serine/Threonine Kinase‐4 Deficiency
di: Buket Kara, et al.
Pubblicazione: (2025)

What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High‐Dose Methotrexate Use in Pediatric Malignancies
di: Zachary L. Taylor, et al.
Pubblicazione: (2025)

Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: A Report From the Children's Oncology Group
di: Jamie M. Aye, et al.
Pubblicazione: (2025)

Characteristics of Transfusion and Association With Oncologic Outcomes in Hepatoblastoma Resection
di: Stephanie F. Polites, et al.
Pubblicazione: (2025)

Factors Associated With Rare Pediatric Cancer Trial Enrollment: A Report From the Children's Oncology Group Rare Tumors Committee
di: Brian R. Englum, et al.
Pubblicazione: (2025)

Indications and Outcomes for Tracheostomies in Pediatric Oncology Patients—A Single Center Study
di: Jonathan Pan, et al.
Pubblicazione: (2024)

Comparing Parent and Child Reports of School Functioning as Predictors of Neurocognitive Test Performance in Hispanic/Latino Survivors of Childhood Leukemia/Lymphoblastic Lymphoma
di: Melissa Balderrama, et al.
Pubblicazione: (2026)

Returning Aggregate Results to Research Participants/Families: Updated Recommendations From the Children's Oncology Group
di: Kathleen S. Ruccione, et al.
Pubblicazione: (2025)

Improving the Safety and Efficacy of Blood Product Administration in the Pediatric Hematology/Oncology Patient Population
di: Claudia J. Heller, et al.
Pubblicazione: (2026)

Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
di: Douglas J. Harrison, et al.
Pubblicazione: (2024)

Evaluating the Utility of Paired Tumor and Germline Targeted DNA Sequencing for Pediatric Oncology Patients: A Single Institution Report
di: Natalie Waligorski, et al.
Pubblicazione: (2026)

Facilitators and Barriers for Implementing Diagnostic Sequencing Technology for Pediatric Oncology in Low‐ and Middle‐Income Countries
di: Kenneth M. Busby, et al.
Pubblicazione: (2026)

Waardenburg Syndrome With T‐Lymphoblastic Lymphoma: A Case Report
di: Neha Da Rocha, et al.
Pubblicazione: (2025)